Senior MSL, Rheumatology – Pacific Northwest (Remote)

Takeda; Washington; Remote; USD 151,000 - 237,000; Full time

Job summary

Takeda is seeking a Senior Medical Science Liaison for the Pacific Northwest, ideally Seattle, WA. This field-based role focuses on external engagement with KOLs and healthcare professionals to advance medical strategy and patient outcomes.

You will disseminate complex data, support investigator-initiated studies, and maintain robust scientific dialogue while adhering to regulatory standards. Travel up to 70% is required, with virtual components for collaboration.

Qualifications

• Excellent communication skills across diverse audiences.
• Strong collaboration and cross-functional teamwork.
• Experience disseminating complex scientific data to healthcare professionals.

Responsibilities

• Externally-focused KOL/HCP activities comprise a minimum of 80% of responsibilities.
• Build and maintain professional relationships with KOLs/HCPs per territory plans.
• Demonstrate advanced knowledge of Takeda disease areas, products, and competitor landscape.
• Support Takeda-sponsored research and assist with medical studies and investigator-initiated research processes.
• Collect, interpret, and communicate medical insights to inform strategies.
• Identify partnership opportunities between KOLs/HCPs and Takeda US Medical.
• Participate in medical strategy at conferences and communicate insights from attendance.
• Complete CRM entries, insights capture, training, and expense reporting in a timely, compliant manner.

Skills

Communication

Collaboration

Virtual teamwork

Education

Doctoral degree in life/health sciences

Master’s degree in health sciences

Job description

Takeda is seeking a Senior Medical Science Liaison for the Pacific Northwest, ideally Seattle, WA. This field-based role focuses on external engagement with KOLs and healthcare professionals to advance medical strategy and patient outcomes.

You will disseminate complex data, support investigator-initiated studies, and maintain robust scientific dialogue while adhering to regulatory standards. Travel up to 70% is required, with virtual components for collaboration.